Compare GSK plc (GSK) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Western Alliance Bancorporation — how do they compare? GSK plc trades at $52.67 (market cap $101.34B), while Western Alliance Bancorporation trades at $84.17 (market cap $8.93B). The key difference: GSK plc is far larger — about 11.3× Western Alliance Bancorporation's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | WAL | |
|---|---|---|
Market Cap | $101.34B | $8.93B |
Sector | Health | Financials |
52-Week High | $61.18 | $96.08 |
52-Week Low | $36.20 | $66.70 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | 2.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Western Alliance Bancorporation (WAL) trades at $83.33, up 3.7% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The stock shows solid fundamentals with a P/E of 9.52, net income margin of 25.63%, and a history of beating earnings estimates in recent quarters. Recent news highlights operational recognition, including being named Arizona's #1 Best Bank by Forbes in June 2026 and announcing a $0.42 dividend for H1-2026.
The outlook is positive given strong profitability, consistent earnings beats, and overwhelming analyst support (79% Buy ratings). Key risks include significant negative operating cash flow in 2025 (-$2.68B) and reliance on financing activities for liquidity. The stock trades below the consensus price target of $90.67, offering potential upside if the company can improve cash generation from operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
